Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 41

Trial Status

Completed4

Role Distribution

Principal Investigator3
Other Roles1
PI Rate75%

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00211198Phase 4StudyChair

Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)

Lymphoma, T-Cell, Cutaneous
Completed
NCT00337987Phase 2PrincipalInvestigator

A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma

Peripheral T-Cell Lymphoma
Completed
NCT00338494Phase 1PrincipalInvestigator

Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma

B-Cell Lymphoma
Completed
NCT00402714Phase 2PrincipalInvestigator

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

Hematologic Malignancies
Completed

All 4 trials loaded